Verastem(VSTM) - 2025 Q4 - Earnings Call Transcript

Verastem (NasdaqCM:VSTM) Q4 2025 Earnings call March 04, 2026 04:30 PM ET Company ParticipantsClara Dong - VP of Equity Research in BiotechnologyDan Calkins - CFODan Paterson - President and CEOJulissa Viana - VP of Corporate Communications, Investor Relations, and Patient AdvocacyMatthew Venezia - Biotechnology Equity Research AssociateMichael Kauffman - President of DevelopmentMike Crowther - Chief Commercial OfficerYuan Zhi - Managing DirectorConference Call ParticipantsEric Schmidt - Biotechnology Analy ...